Abstract:Introduction Peripheral arterial disease (PAD) is increasingly prevalent, and supervised physical exercise programmes are recommended as the first-line treatment. However, these programmes are underused. Alternative delivery models may be able to expand treatment coverage. The objective of this study was to compare a home-based exercise programme (HBEP) and a centre-based exercise (CBE) in terms of their effects on functional capacity, peripheral muscle oxygenation and quality of life in individuals with PAD. Methods and analysis This single-blind, parallel randomised clinical trial will consist of two groups: HBEP and CBE. A qualitative analysis will be carried out to investigate acceptability and satisfaction. The primary outcome will be functional capacity, assessed by the incremental shuttle walk test. Secondary outcomes will include functional capacity, assessed by a treadmill walking test; peripheral muscle oxygenation and quality of life; and self-reported functional impairment, risk factors, morbidity, level of physical activity, adherence, acceptability and satisfaction. The intervention protocols will consist of 12 weeks of intermittent walking until claudication symptoms, three times a week. Participants randomly assigned to the CBE group will participate in supervised face-to-face sessions. The HBEP group will perform exercises at home with remote supervision, monitored by a pedometer and heart rate monitor, and subjective perception of effort during each session will be recorded by participants in a training diary; follow-up will be conducted by telephone calls. Statistical analyses will follow the intention-to-treat principle. Participants allocated to the HBEP group will be interviewed about their experience of remote treatment using a qualitative approach. Ethics and dissemination Ethics approval was obtained from the Ethics Committee of the Universidade Federal de Minas Gerais. The results will be disseminated in a peer-reviewed journal and presented at international congresses. This research has the potential to improve the care of people with PAD because if home-based rehabilitation demonstrates effectiveness, it could be considered an alternative or support resource to the usual centre-based treatment models, expanding access, coverage and participation in vascular physiotherapy Trial registration https://ensaiosclinicos.gov.br/rg/RBR-97vy9n7 on 14 April 2022.

Daly/Cost comparison in the management of peripheral arterial disease at 17 Belgian hospitals

Prioritization of Treatments for Lower Extremity Peripheral Artery Disease in Low- and Middle-Income Countries

Strategies to reduce out-of-pocket medication costs for Canadians with peripheral arterial disease

A retrospective cost analysis of angioplasty compared to bypass surgery for lower limb arterial disease in an Australian tertiary health service

Cost-effectiveness of diagnostic imaging modalities in symptomatic patients with lower limb peripheral arterial disease: discrete event simulation model

Two-year PAD-related health care costs in patients undergoing lower extremity endovascular revascularization: results from the LIBERTY 360° trial

Clinical Outcomes and Resource Utilization in Patients with Peripheral Arterial Disease Hospitalized for Acute Coronary Syndrome

A retrospective analysis on optimal medical therapy for patients with symptomatic lower extremity peripheral artery disease: a French observational study

Impact of diabetes on medical costs in the pre- and postoperative year of lower extremity amputations in Belgium

Lower extremity arterial disease in patients with diabetes: a contemporary narrative review

Biopsychosocial Assessment and Intervention on Vascular Diseases of Lower Extremities

Peripheral artery disease in patients with stable coronary artery disease in general practice: results from an Italian nationwide study—PAD & CAD study

Practice Patterns of Peripheral Vascular Interventions for Peripheral Artery Disease in the Office-Based Laboratory Setting versus Outpatient Hospital

Peripheral artery disease: epidemiology and global perspectives

Revascularisation for Peripheral Arterial Disease in France: Implications for the Implementation of VOYAGER-PAD

Estimation Of Medical Treatment For Peripheral Arterial Disease In Chinese High-Risk Patients

Association of health status and hospitalization risk for peripheral artery disease in the PORTRAIT registry

Peripheral arterial disease--what do we need to know?

Impact of a national guideline for the management of peripheral arterial disease on revascularization rates in England: interrupted time series analysis

Comparison of home-based rehabilitation and a centre-based exercise in terms of functional capacity, muscle oxygenation and quality of life in people with peripheral arterial disease: a protocol for a randomised controlled trial

An unfavorable dietary pattern is associated with symptomatic peripheral artery disease